ValueWalk’s May 2022 Hedge Fund Update: Melvin Capital Plans Restructure

[Valuewalk premium advertisement ad unit]() ​ ​[ValueWalk’s May 2022 Hedge Fund Update: Melvin Capital Plans Restructure](=)​ Welcome to our latest issue of issue of ValueWalk’s hedge fund update. Below subscribers can find an excerpt in text and the full issue in PDF format. Please send us your feedback! Featuring Melvin Capital plans restructure, a jump in hedge fund launches, and Oaktree Capital branches out with partnerships. Q1 2022 hedge fund letters, […] [Read More](=)​ ​[How Institutions Are Making Money On Crypto And What’s Needed For Greater Adoption](​ In recent years, a growing number of hedge fund managers have started dipping their proverbial toes into the crypto space. Many well-known gurus like Warren Buffett have said they will never invest in any cryptocurrencies, with Buffett calling them "rat poison." However, it seems clear now that cryptocurrencies won't go away any time soon. Dan […] [Read More](​ ​[Apple Warns It Is Not Immune From Supply Chain Disruptions](=)​ In his Daily Market Notes report to investors, while commenting on Apple, Louis Navellier wrote: Healthy Consumer Spending The Commerce Department announced that personal consumption expenditures rose 1.1% in March, while personal income rose by 0.5%. Anytime consumers spend more than their income by drawing down savings or incurring new debt is a sign of […] [Read More](=)​ ​[Biden’s Anti-Inflation Agenda Is Lacking](​ In his State of the Union address last night, President Joe Biden told Americans that he had a realistic plan for bringing down inflation. The agenda he laid out, however, has little chance of doing so. Q4 2021 hedge fund letters, conferences and more [Read More](​ ​[AstraZeneca – Cash Concerns Loom As Spending Continues](=)​ AstraZeneca plc (LON:AZN)’s first quarter revenue beat expectations and rose 60% to $11.4bn ignoring the impact of exchange rates. This was driven by growth in most categories, the contribution of Alexion’s portfolio of products and Covid-vaccine contracts. Cash profits (EBITDA) fell 16% to $2.2bn, lower than market expectations. This reflected costs associated with the Alexion […] [Read More](=)​ ​[Apple’s Numbers Complete Trifecta]()​ You could almost hear the collective sigh of relief after Apple (NASDAQ:AAPL) released its latest earnings report at the end of yesterday’s session. Investors have already found solace this week with solid results from Microsoft (NASDAQ:MSFT) and Facebook (NASDAQ:FB) helping to at least slow the wave of risk-off sentiment that’s rattled the equity markets. After […] [Read More]()​ ​ [facebook]() [twitter]() [linkedin]() [instagram](=) Copyright 2021 VALUEWALK LLC, All rights reserved. You are receiving this email because you subscribed to this newsletter on [valuewalk.com]() [Unsubscribe]( or the 295 Madison Avenue 12th floor, New York, NY 10117 973-685-6523